Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data

Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data

Background: Aromatase inhibitors (AIs) are the preferred endocrine treatment for postmenopausal hormonal receptor-positive breast cancer. However, there is controversy on the long-term cardiovascular and cerebrovascular safety of AIs over that of tamoxifen. Methods: We analyzed the National Health I...

Full description

Bibliographic Details
Main Authors: Sung Hyouk Choi, Kyoung-Eun Kim, Yujin Park, Young Wook Ju, Ji-Gwang Jung, Eun Shin Lee, Han-Byoel Lee, Wonshik Han, Dong-Young Noh, Hyung-Jin Yoon, Hyeong-Gon Moon
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Breast
Subjects:
Breast cancer
Aromatase inhibitors
Tamoxifen
Cardiovascular disease
Cerebrovascular disease
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977620301569

Internet

http://www.sciencedirect.com/science/article/pii/S0960977620301569

Similar Items